scholarly article | Q13442814 |
P2093 | author name string | Rae R Matsumoto | |
Andrew Coop | |||
Buddy Pouw | |||
Aisha L Mack | |||
Antawan Daniels | |||
P2860 | cites work | Rimcazole analogs attenuate the convulsive effects of cocaine: correlation with binding to sigma receptors rather than dopamine transporters | Q28202676 |
Sigma receptors: potential medications development target for anti-cocaine agents | Q28208121 | ||
Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides | Q28215345 | ||
Sigma receptors: biology and therapeutic potential | Q28266963 | ||
The analgesic tropane analogue (+/-)-SM 21 has a high affinity for sigma2 receptors | Q28372452 | ||
Two novel sigma receptor ligands, BD1047 and LR172, attenuate cocaine-induced toxicity and locomotor activity | Q28376445 | ||
Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes | Q34326129 | ||
Cocaine, reward, movement and monoamine transporters | Q34502175 | ||
Cocaine binding at sigma receptors. | Q34555132 | ||
Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity | Q34804462 | ||
Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates | Q38315024 | ||
Cocaine-induced convulsions: pharmacological antagonism at serotonergic, muscarinic and sigma receptors | Q42550669 | ||
Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism | Q42557456 | ||
(+/-)-SM 21 attenuates the convulsive and locomotor stimulatory effects of cocaine in mice | Q43574377 | ||
Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1. | Q43849727 | ||
N-arylalkylpiperidines as high-affinity sigma-1 and sigma-2 receptor ligands: phenylpropylamines as potential leads for selective sigma-2 agents | Q43869049 | ||
sigma(2) Receptors regulate changes in sphingolipid levels in breast tumor cells | Q44014688 | ||
Synthesis of N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl carbamate analogs as sigma2 receptor ligands | Q46156850 | ||
Ibogaine and its congeners are sigma 2 receptor-selective ligands with moderate affinity | Q46323624 | ||
Synthesis and in vivo evaluation of a new PET radioligand for studying sigma-2 receptors | Q46465098 | ||
CB-64D and CB-184: ligands with high σ2 receptor affinity and subtype selectivity | Q46698599 | ||
(E)-8-benzylidene derivatives of 2-methyl-5-(3-hydroxyphenyl)morphans: highly selective ligands for the sigma 2 receptor subtype | Q46912350 | ||
[3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes | Q48818603 | ||
Pharmacological identification of SM-21, the novel sigma(2) antagonist | Q49059458 | ||
Secondary amine analogues of 3 beta-(4'-substituted phenyl)tropane-2 beta-carboxylic acid esters and N-norcocaine exhibit enhanced affinity for serotonin and norepinephrine transporters. | Q51636071 | ||
Inotropic action of sigma receptor ligands in isolated cardiac myocytes from adult rats | Q70911420 | ||
Ibogaine possesses a selective affinity for σ2 receptors | Q71852379 | ||
Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 1. 3-(omega-aminoalkyl)-1H-indoles | Q72317740 | ||
A comparison of (-)-deoxybenzomorphans devoid of opiate activity with their dextrorotatory phenolic counterparts suggests role of sigma 2 receptors in motor function | Q72954030 | ||
Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells | Q73478851 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 86-91 | |
P577 | publication date | 2006-12-22 | |
P1433 | published in | Pharmacology, Biochemistry and Behavior | Q15716554 |
P1476 | title | Effects of UMB24 and (+/-)-SM 21, putative sigma2-preferring antagonists, on behavioral toxic and stimulant effects of cocaine in mice | |
P478 | volume | 86 |
Q39297889 | 2-Aminopyridine derivatives as potential σ(2) receptor antagonists |
Q35197016 | A Role for Sigma Receptors in Stimulant Self Administration and Addiction. |
Q24611779 | A novel substituted piperazine, CM156, attenuates the stimulant and toxic effects of cocaine in mice |
Q43450779 | A selective sigma-2 receptor ligand antagonizes cocaine-induced hyperlocomotion in mice. |
Q34093326 | Antidepressant-like effect of PRE-084, a selective sigma1 receptor agonist, in Albino Swiss and C57BL/6J mice |
Q34383909 | Chlorophenylpiperazine analogues as high affinity dopamine transporter ligands. |
Q50323703 | Cocaine Effects on Dopaminergic Transmission Depend on a Balance between Sigma-1 and Sigma-2 Receptor Expression |
Q36494168 | Cocaine occupancy of sigma1 receptors and dopamine transporters in mice |
Q36372881 | Ethanol-related behaviors in mice lacking the sigma-1 receptor |
Q36793936 | Nitrile analogs of meperidine as high affinity and selective sigma-1 receptor ligands |
Q37739145 | Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish. |
Q37545379 | Pharmacology and therapeutic potential of sigma(1) receptor ligands |
Q37357475 | Selective reduction of alcohol drinking in Sardinian alcohol-preferring rats by a sigma-1 receptor antagonist |
Q39185737 | Sigma Receptors and Substance Use Disorders |
Q33613556 | Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor kappaB |
Q34362333 | Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy. |
Q24615155 | Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice |
Q88574251 | Small molecule modulators of σ2R/Tmem97 reduce alcohol withdrawal-induced behaviors |
Q36737209 | Synthesis and σ1 Receptor Binding of Halogenated N,N'-Diphenethylethylenediamines |
Q24622567 | Targeting sigma receptors: novel medication development for drug abuse and addiction |
Q36107398 | The effect of the pyridyl nitrogen position in pyridylpiperazine sigma ligands |
Q24614102 | The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism |
Q24658287 | The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking |
Search more.